Related Experiment Video

Updated: May 9, 2025

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation
09:32

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on: February 28, 2025

487

Unlocking tumor-infiltrating lymphocyte potential with CRISPR-Cas9

Özcan Met1, Inge Marie Svane2

  • 1National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.

The Lancet. Oncology
|May 2, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells07:56

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

11.0K
Production of Human CRISPR-Engineered CAR-T Cells06:33

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

12.6K

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
48.5K